Biomarker Testing Services Market Size, Share & Trends Report

Biomarker Testing Services Market Size, Share & Trends Analysis Report By End-user, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453168
  • Number of Pages: 0
  • Format: Electronic (PDF)

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment Scope
                       1.1.2 Regional Scope
                       1.1.3 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database:
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach: Commodity Flow Approach
                   1.7 Research Assumptions
                   1.8 List of Secondary Sources
                   1.9 List of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 Objective 2
                       1.10.3 Objective 3
                       1.10.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Biomarker Testing Services Market Variables, Trends, and Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Ancillary Market Outlook
                   3.2 Penetration and Growth Prospect Mapping
                   3.3 Market Dynamics
                       3.3.1 Market Drivers Analysis
                       3.3.2 Market Restraint Analysis
                   3.4 Biomarkers Testing Services: Market Analysis Tools
                       3.4.1 Industry Analysis: Porter’s Five Forces Analysis
                       3.4.2 Pestle Analysis
                       3.4.3 Major Deals And Strategic Alliances
                       3.4.4 COVID- 19 Impact Analysis
Chapter 4 Biomarkers Testing Services Market: Segment Analysis, By Services, 2018 - 2030 (USD Million)
                   4.1 Definition and Scope
                   4.2 Services Market Share Analysis, 2021 & 2030
                   4.3 Segment Dashboard
                   4.4 Global Biomarker Testing Market, by Services, 2018 to 2030
                   4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       4.5.1 Biomarker Assay Development
                           4.5.1.1 Biomarker assay development market, 2018 - 2030 (USD Million)
                       4.5.2 Biomarker assay validation
                           4.5.2.1 Biomarker assay validation market, 2018 - 2030 (USD Million)
                       4.5.3 Biomarker Assessment
                           4.5.3.1 Biomarker assessment market, 2018 - 2030 (USD Million)
                       4.6.4 Others
                           4.6.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 5 Biomarkers Testing Services Market: Segment Analysis, By Therapeutic area, 2018 - 2030 (USD Million)
                   5.1 Definition and Scope
                   5.2 Therapeutic Area Market Share Analysis, 2021 & 2030
                   5.3 Segment Dashboard
                   5.4 Global Biomarkers Testing Services Market, by Therapeutic area, 2018 to 2030
                   5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       5.5.1 Cardiovascular Disease
                           5.5.1.1 Cardiovascular Disease market, 2018 - 2030 (USD Million)
                       5.5.2 Immunology
                           5.5.2.1 Immunology market, 2018 - 2030 (USD Million)
                       5.5.3 Infectious Disease
                           5.5.3.1 Infectious disease market, 2018 - 2030 (USD Million)
                       5.5.4 Inflammation
                           5.5.4.1 Inflammation market, 2018 - 2030 (USD Million)
                       5.5.5 Metabolism
                           5.5.5.1 Metabolism market, 2018 - 2030 (USD Million)
                       5.5.6 Neuroscience
                           5.5.6.1 Neuroscience market, 2018 - 2030 (USD Million)
                       5.5.7 Ophthalmology
                           5.5.7.1 Ophthalmology market, 2018 - 2030 (USD Million)
                       5.5.8 Oncology
                           5.5.8.1 Oncology market, 2018 - 2030 (USD Million)
                       5.5.9 Renal Disorders
                           5.5.9.1 Renal Disorders market, 2018 - 2030 (USD Million)
                       5.5.10 Respiratory Disease
                           5.5.10.1 Respiratory Disease market, 2018 - 2030 (USD Million)
Chapter 6 Biomarkers Testing Services Market: Segment Analysis, By End-user, 2018 - 2030 (USD Million)
                   6.1 Definition and Scope
                   6.2 End-user Market Share Analysis, 2021 & 2030
                   6.3 Segment Dashboard
                   6.4 Global Biomarkers Testing Services Market, by End-user, 2018 to 2030
                   6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       6.5.1 Pharmaceutical and biotechnology companies
                           6.5.1.1 Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
                       6.5.2 Research Institutes
                           6.5.2.1 Research institutes market, 2018 - 2030 (USD Million)
                       6.5.3 CROs
                           6.5.3.1 CROs market, 2018 - 2030 (USD Million)
Chapter 7 Biomarker Testing Services Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
                   7.1 Definition & Scope
                   7.2 Regional Market Share Analysis, 2021 & 2030
                   7.3 Regional Market Dashboard
                   7.4 Regional Market Snapshot
                   7.5 Regional Market Share and Leading Players, 2021
                       7.5.1 North America
                       7.5.2 Europe
                       7.5.3 Asia Pacific
                       7.5.4 Latin America
                       7.5.5 Middle East And Africa
                   7.6 SWOT Analysis
                       7.6.1 North America
                       7.6.2 Europe
                       7.6.3 Asia Pacific
                       7.6.4 Latin America
                       7.6.5 Middle East And Africa
                   7.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
                       7.7.1 North America
                           7.7.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
                           7.7.1.2 U.S.
                               7.7.1.2.1 U.S. biomarkers market, 2018 - 2030 (USD Million)
                           7.7.1.3 Canada
                               7.7.1.3.1 Canada biomarkers market, 2018 - 2030 (USD Million)
                       7.7.2 Europe
                           7.7.2.1 Europe biomarkers market, 2018 - 2030 (USD Million)
                           7.7.2.2 U.K.
                               7.7.2.2.1 U.K. biomarkers market, 2018 - 2030 (USD Million)
                           7.7.2.3 Germany
                               7.7.2.3.1 Germany biomarkers market, 2018 - 2030 (USD Million)
                           7.7.2.4 Spain
                               7.7.2.4.1 Spain biomarkers market, 2018 - 2030 (USD Million)
                           7.7.2.5 France
                               7.7.2.5.1 France biomarkers market, 2018 - 2030 (USD Million)
                           7.7.2.6 Italy
                               7.7.2.6.1 Italy biomarkers market, 2018 - 2030 (USD Million)
                       7.7.3 Asia Pacific
                           7.7.3.1 Asia Pacific biomarkers market, 2018 - 2030 (USD Million)
                           7.7.3.2 Japan
                               7.7.3.2.1 Japan biomarkers market, 2018 - 2030 (USD Million)
                           7.7.3.3 China
                               7.7.3.3.1 China biomarkers market, 2018 - 2030 (USD Million)
                           7.7.3.4 India
                               7.7.3.4.1 India biomarkers market, 2018 - 2030 (USD Million)
                           7.7.3.5 South Korea
                               7.7.3.5.1 South Korea biomarkers market, 2018 - 2030 (USD Million)
                           7.7.3.6 Australia
                               7.7.3.6.1 Australia biomarkers market, 2018 - 2030 (USD Million)
                       7.7.4 Latin America
                           7.7.4.1 Latin America biomarkers market, 2018 - 2030 (USD Million)
                           7.7.4.2 Brazil
                               7.7.4.2.1 Brazil biomarkers market, 2018 - 2030 (USD Million)
                           7.7.4.3 Mexico
                               7.7.4.3.1 Mexico biomarkers market, 2018 - 2030 (USD Million)
                           7.7.4.4 Argentina
                               7.7.4.4.1 Argentina biomarkers market, 2018 - 2030 (USD Million)
                       7.7.5 MEA
                           7.7.5.1 MEA biomarkers market, 2018 - 2030 (USD Million)
                           7.7.5.2 South Africa
                               7.7.5.2.1 South Africa biomarkers market, 2018 - 2030 (USD Million)
                           7.7.5.3 Saudi Arabia
                               7.7.5.3.1 Saudi Arabia biomarkers market, 2018 - 2030 (USD Million)
                           7.7.5.4 UAE
                               7.7.5.4.1 UAE biomarkers market, 2018 - 2030 (USD Million)
Chapter 8 Biomarker Testing Services Market: Competitive Analysis
                   8.1 Company Profiles
                       8.1.1 BioAgilytix Labs.
                           8.1.1.1 Company overview
                           8.1.1.2 Financial performance
                           8.1.1.3 Product benchmarking
                           8.1.1.4 Strategic initiatives
                       8.1.2 Eurofins Scientific
                           8.1.2.1 Company overview
                           8.1.2.2 Financial performance
                           8.1.2.3 Product benchmarking
                           8.1.2.4 Strategic initiatives
                       8.1.3 SGS SA
                           8.1.3.1 Company overview
                           8.1.3.2 Financial performance
                           8.1.3.3 Product benchmarking
                           8.1.3.4 Strategic initiatives
                       8.1.4 Charles River Laboratories
                           8.1.4.1 Company overview
                           8.1.4.2 Financial performance
                           8.1.4.3 Product benchmarking
                           8.1.4.4 Strategic initiatives
                       8.1.5 Labcorp Drug Development
                           8.1.5.1 Company overview
                           8.1.5.2 Financial performance
                           8.1.5.3 Product benchmarking
                           8.1.5.4 Strategic initiatives
                       8.1.6 PPD, Inc.
                           8.1.6.1 Company overview
                           8.1.6.2 Financial performance
                           8.1.6.3 Product benchmarking
                           8.1.6.4 Strategic initiatives
                       8.1.7 ICON Plc
                           8.1.7.1 Company overview
                           8.1.7.2 Financial performance
                           8.1.7.3 Product benchmarking
                           8.1.7.4 Strategic initiatives
                       8.1.8 IQVIA
                           8.1.8.1 Company overview
                           8.1.8.2 Financial performance
                           8.1.8.3 Product benchmarking
                           8.1.8.4 Strategic initiatives
                       8.1.9 Syneos Health
                           8.1.9.1 Company overview
                           8.1.9.2 Financial performance
                           8.1.9.3 Product benchmarking
                           8.1.9.4 Strategic initiative
                       8.1.10 Intertek Group Plc
                           8.1.10.1 Company overview
                           8.1.10.2 Financial performance
                           8.1.10.3 Product benchmarking
                           8.1.10.4 Strategic initiatives



What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.